GSTM1 null genotype underpins recurrence of NF2 meningiomas
Anthony C. Johnson(University of Oklahoma Health Sciences Center), Ian F. Dunn(University of Oklahoma), Alla V. Tsytsykova(Boston Children's Hospital), Pamela S. Jones(Massachusetts General Hospital), Khanh P. Phan(University of Oklahoma Health Sciences Center), Tressie M. Stephens(University of Oklahoma Health Sciences Center), Christopher S. Graffeo(Oklahoma City University), Sanaa Hameed(University of Oklahoma Health Sciences Center), Gavin P. Dunn(Brigham Young University), Andrew M. Bauer(Cleveland Clinic), Yufeng Liu(Xijing Hospital), Erdyni N. Tsitsikov(Harvard University), Jeffrey Zuccato(University of Oklahoma)
Cited by 1
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|808
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
Emerging insights into the molecular and cellular basis of glioblastoma
|Genes & Development|2012|568
Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
|CNS Neuroscience & Therapeutics|2015|386